期刊文献+

人乳腺珠蛋白基因亚型的原核表达及纯化 被引量:2

Prokaryotic expression and purification of two human mammaglobin gene subtypes
下载PDF
导出
摘要 目的:克隆人乳珠蛋白(hMAM)编码全长cDNA,原核表达并纯化蛋白产物,为后期研制乳腺癌早期诊断试剂盒奠定基础。方法:自乳腺癌组织及乳腺癌细胞株MD-MB453提取总RNA,通过RT-PCR克隆hMAM cD-NA,构建pQE40-hMAM表达质粒,在大肠杆菌M15中表达,利用镍-亚硝胺乙酸组氨酸(N i-NTA-H is)亲和层析法对重组蛋白进行纯化。结果:乳腺癌组织和乳腺癌细胞株中发现两种hMAM cDNA亚型,即hMAM和hMAM(Isoform),长度分别为279和270 bp,两者相差9个连续碱基,其翻译产物相差3个连续氨基酸残基;表达的融合蛋白以不溶性包涵体形式存在,纯化后得到纯度为97%的目的蛋白。结论:获得hMAM cDNA并发现一个新的hMAM突变体;融合蛋白的表达及纯化成功。 Objective : To clone the cDNA in full-length of human mammaglobin, do prokaryotic expression and purify hMAM protein, as a basis for early diagnosis of breast cancer. Methods : hMAM cDNA was amplified through RT-PCR from breast cancer tissue and breast cancer cell line MD-MB453, and the recombination pQE40-hMAM vector was constructed and expressed in E. Coli. M15 after induction by IPTG. The fusion protein was purified with Ni-NTA-His mffinity chromatography. Results: Two subtypes of hMAM cDNA and the hMAM (Isoform) cDNA were found, in which consisted of 270 bp, different from the wildtype hMAM cDNA of 279 bp on nine continuous base pair missing . The fusion protein formed inclusion body in prokaryotic expression system and the renatured protein was purified which purity was about 97%. Conclusion : The recombinant hMAM was successfully purified.
出处 《医学研究生学报》 CAS 2006年第2期107-110,共4页 Journal of Medical Postgraduates
基金 重庆市科委应用基础研究基金资助项目(批准号:200407) 第三军医大学归国人员启动资金资助项目(批准号:XG200363)
关键词 乳腺癌 人乳腺珠蛋白 原核表达系统 蛋白纯化 Breast cancer Human mammaglobin Prokaryotic expression system Protein purification
  • 相关文献

参考文献11

  • 1Watson MA, Fleming TP. Mammaglobin, a mammary - specific member of the ueteroglobin gene family, is overexpressed in human breast cancer[ J ]. Cancer Res, 1996,56 (4) : 860-865. 被引量:1
  • 2Carter D, Douglass JF, Cornellison CD, et al. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer[ J ]. Biochemistry,2002,41 (21) :6714-6722. 被引量:1
  • 3Zehentner BK,Deme A,Toure P,et al. Mammaglobin as a novel breast cancer biomarker:muhigene reverse transcription-PCR assay and sandwich ELISA[ J]. Clin Chem,2004,50( 11 ) :2069-2076. 被引量:1
  • 4O' Brien N, Maguire TM, O' Donovan N, et al. Mammaglobin A: a promising marker for breast cancer [ J ]. Clin Chem, 2002,48(8) :1362-1364. 被引量:1
  • 5Grunewald K, Haun M, Urbanek M ,et al. Mammaglobin gene expression:a superior marker of breast cancer cells in peripheral blood in comparison to epidermal growth factor receptor or cytokeratin-19[ J]. Lab Invest,2000,80(7 ) : 1071-1077. 被引量:1
  • 6Fleming TP, Watson MA. Mammaglobin, a breast-specific gene,and its utility as a marker fur breast cancer[ J ]. Annals New Academy Sci ,2000,923 (5) :78-89. 被引量:1
  • 7郑莹,李德録,向泳梅,李新建.上海市区乳腺癌流行现状及趋势分析[J].外科理论与实践,2001,6(4):219-221. 被引量:91
  • 8张群,陈龙邦,臧静,褚晓源,王靖华,耿怀成.乳腺癌患者尿液基质金属蛋白酶检测的临床意义[J].医学研究生学报,2003,16(8):594-595. 被引量:3
  • 9周新 涂植光.临床生物化学和生物化学检验[M](第3版)[M].北京:人民卫生出版社,2004.447-470. 被引量:8
  • 10Bostic PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse-transcriptiase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients [ J ]. Clin Oncol. 1998.16 ( 11 ) : 2632-2640. 被引量:1

二级参考文献7

  • 1彭宁宁,王芝瑛,高根娣.上海市学生营养状况分析[J].上海预防医学,1999,11(9):389-391. 被引量:23
  • 2吴其乐,蒋家,施爱珍.上海地区三次居民营养调查比较[J].上海预防医学,1995,7(C00):2-5. 被引量:8
  • 3Massova I, Kotra LP, Fridman R et al. Matrix metalloproteinases: structure, substrate specificities, evolution and diversification[J]. FASEB J,1998,12(5):1075-1095. 被引量:1
  • 4Olson MW, Bernardo M, Pietila M et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9 differential rates for activation by stromelysin 1[J]. J Biol Chem,2000,275(5):2661-2668. 被引量:1
  • 5Bianco FJ, Grignon DJ, Pontes JE et al. Gelatinase B (MMP-9) overexpression in bladder washing specimens predicts pathological stage and grade in bladder cancer patients[J]. Clin Cancer Res,1998,4(10):3011-3016. 被引量:1
  • 6Davies B,Miles LC,Happerfield MS et al.Activity of type Ⅳ collagenase in benign and malignant breast disease[J].Br J Cancer,1993,67(5):1126-1131. 被引量:1
  • 7Hayes DF, Zurawski VR, Kufe DW. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer[J]. J Clin Oncol, 1986,4(7):1542-1550. 被引量:1

共引文献98

同被引文献32

  • 1李英辉,刘军,赵亚,薛采芳,丁劲,黄豫晓.HBV靶向核糖核酸酶基因的原核表达和纯化及多克隆抗体的制备[J].医学研究生学报,2005,18(4):295-297. 被引量:8
  • 2何小平,李兆申,屠振兴,高军,潘雪,龚燕芳,金晶.人canstatin基因原核载体构建及其重组蛋白的表达纯化[J].医学研究生学报,2005,18(11):981-985. 被引量:4
  • 3Boyd MR, Gustafson KR, McMahon JB, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprutein gp120:potential applications to microbicide development[ J ]. Antimicrob Agents Chemother, 1997, 41(7): 1521-1530. 被引量:1
  • 4Botos I, Wlodawer A. Cyanovirin-N: a sugar-binding antiviral protein with a new twist [ J ]. Cell Mol Life Sci, 2003,60 ( 2 ) : 277 -287. 被引量:1
  • 5Bolmstedt AJ, O' Keefe BR, Shenoy SR, et al. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high- mannose glycans in an oligosaccharide-specific manner [ J ]. Mol Pharmacol,2001,59 ( 5 ) :949-954. 被引量:1
  • 6Dey B, Lerner DL, Lusso P, et al. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gpl20 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses [ J ]. J Viral, 2000, 74 (10) : 4562- 4569. 被引量:1
  • 7J萨姆布鲁克著.黄培堂译.分子克隆实验指南[M].北京:科学出版社,2002:1-118. 被引量:2
  • 8Han Z, Simpson JT, Fivash MJ, et al. Identification and characterization of peptides that bind to cyanovirin-N, a potent human immunodeficiency virus-inactivating protein [ J ]. Peptides, 2004, 25(4) :551-562. 被引量:1
  • 9O' Keefe BR,Smee DF,Turpin JA, et al. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin [ J ]. Antimicrob Agents Chemother, 2003, 47 (8) :2518-2525. 被引量:1
  • 10Barrientos LG, Gronenborn AM. The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy [J]. Mini Rev Med Chem,2005, 5(1) : 21-31. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部